These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 15533659)
1. An analytical perspective on favoured synthetic routes to the psychoactive tryptamines. Brandt SD; Freeman S; McGagh P; Abdul-Halim N; Alder JF J Pharm Biomed Anal; 2004 Nov; 36(4):675-91. PubMed ID: 15533659 [TBL] [Abstract][Full Text] [Related]
2. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part III. Characterisation of the Speeter and Anthony route to N,N-dialkylated tryptamines using CI-IT-MS-MS. Brandt SD; Freeman S; Fleet IA; Alder JF Analyst; 2005 Sep; 130(9):1258-62. PubMed ID: 16096671 [TBL] [Abstract][Full Text] [Related]
3. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR. Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF Analyst; 2005 Mar; 130(3):330-44. PubMed ID: 15724162 [TBL] [Abstract][Full Text] [Related]
4. Analytical characterisation of the routes by thermolytic decarboxylation from tryptophan to tryptamine using ketone catalysts, resulting in tetrahydro-beta-carboline formation. Brandt SD; Mansell D; Freeman S; Fleet IA; Alder JF J Pharm Biomed Anal; 2006 Jun; 41(3):872-82. PubMed ID: 16569488 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines. Brandt SD; Tearavarich R; Dempster N; Cozzi NV; Daley PF Drug Test Anal; 2012 Jan; 4(1):24-32. PubMed ID: 22287290 [TBL] [Abstract][Full Text] [Related]
6. Fingerprint analysis of thermolytic decarboxylation of tryptophan to tryptamine catalyzed by natural oils. Martins CP; Awan MA; Freeman S; Herraiz T; Alder JF; Brandt SD J Chromatogr A; 2008 Nov; 1210(1):115-20. PubMed ID: 18823897 [TBL] [Abstract][Full Text] [Related]
7. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Brandt SD; Kavanagh PV; Dowling G; Talbot B; Westphal F; Meyer MR; Maurer HH; Halberstadt AL Drug Test Anal; 2017 Jan; 9(1):115-126. PubMed ID: 27100373 [TBL] [Abstract][Full Text] [Related]
8. Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. Brandt SD; Freeman S; Fleet IA; McGagh P; Alder JF Analyst; 2004 Nov; 129(11):1047-57. PubMed ID: 15508033 [TBL] [Abstract][Full Text] [Related]
9. Toxicology and Analysis of Psychoactive Tryptamines. Malaca S; Lo Faro AF; Tamborra A; Pichini S; Busardò FP; Huestis MA Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291798 [TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of emerging psychoactive substances by ion mobility spectrometry. Armenta S; Garrigues S; de la Guardia M; Brassier J; Alcalà M; Blanco M; Perez-Alfonso C; Galipienso N Drug Test Anal; 2015 Apr; 7(4):280-9. PubMed ID: 24935207 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives. Shimazu S; Miklya I Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):421-7. PubMed ID: 15093948 [TBL] [Abstract][Full Text] [Related]
12. An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'. Arunotayanun W; Dalley JW; Huang XP; Setola V; Treble R; Iversen L; Roth BL; Gibbons S Bioorg Med Chem Lett; 2013 Jun; 23(11):3411-5. PubMed ID: 23602445 [TBL] [Abstract][Full Text] [Related]
13. Some new psychoactive substances: precursor chemicals and synthesis-driven end-products. Collins M Drug Test Anal; 2011; 3(7-8):404-16. PubMed ID: 21755608 [TBL] [Abstract][Full Text] [Related]
14. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices. Gaujac A; Navickiene S; Collins MI; Brandt SD; de Andrade JB Drug Test Anal; 2012; 4(7-8):636-48. PubMed ID: 22577086 [TBL] [Abstract][Full Text] [Related]
16. Bioanalysis of new designer drugs. Wohlfarth A; Weinmann W Bioanalysis; 2010 May; 2(5):965-79. PubMed ID: 21083227 [TBL] [Abstract][Full Text] [Related]
17. Arylethylamine psychotropic recreational drugs: a chemical perspective. Freeman S; Alder JF Eur J Med Chem; 2002 Jul; 37(7):527-39. PubMed ID: 12126772 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of nineteen hallucinogenic tryptamines/beta-calbolines and phenethylamines using gas chromatography-mass spectrometry and liquid chromatography-electrospray ionisation-mass spectrometry. Kikura-Hanajiri R; Hayashi M; Saisho K; Goda Y J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(1):29-37. PubMed ID: 16154520 [TBL] [Abstract][Full Text] [Related]